Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008
Calprotectin as new sensitive marker of neutrophilic inflammation in patients with bronchiolitis obliterans Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018
Short-term variation of lung function and airway inflammation in children and adolescents with bronchiolitis obliterans Source: International Congress 2016 – Orphan diseases I Year: 2016
Chronic lung allograft rejection: prevalence, pathology, risk factors and pathophysiology Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=1 Year: 2004
Changes of the lung function parameters in patients with mild bronchiolitis obliterans Source: Eur Respir J 2001; 18: Suppl. 33, 260s Year: 2001
Neutrophil mediated matrixmetalloproteinase activity is increased in bronchiolitis obliterans syndrome after lung transplantation Source: Eur Respir J 2004; 24: Suppl. 48, 179s Year: 2004
Markers of pulmonary injury and inflammation are elevated in the serum of patients with chronic cough Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Serum chitotriosidase levels in granulomatous lung disorders Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006
Elevated lung clearance index (LCI) as an early marker of future bronchiolitis obliterans (BOS) post lung transplant Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy Source: Eur Respir J 2008; 32: 832-842 Year: 2008
The effect of baseline lung function on the determination of time to bronchiolitis obliterans syndrome Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007
The effect of baseline lung function on the determination of time to bronchiolitis obliterans syndrome Source: Eur Respir Rev 2008; 17: 90-92 Year: 2008
The role of systemic markers of inflammation in bronchiectasis. Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019
IL8 and IL17 are upregulated in BAL fluid of lung transplant patients with bronchiolitis obliterans syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 465s Year: 2004
Levels of TNF-a in blood serum and BALF from children with bronchiolitis obliterans depending on severity of disease Source: Eur Respir J 2005; 26: Suppl. 49, 29s Year: 2005
Can we predict development of bronchiolitis obliterans syndrome (BOS) according to parameters of oxidative stress in lung transplant recipients? Source: Annual Congress 2007 - New insights into clinical lung transplantation Year: 2007
The role of leptin in pulmonary neutrophilia during murine acute lung injury Source: Annual Congress 2011 - Lung cell injury and repair Year: 2011
Inflammatory markers during bronchiolitis, relation to persistent asthma? Source: Annual Congress 2010 - Risk factors for allergic diseases in children Year: 2010
Elevated alveolar antioxidant levels in chronic fibrosing interstitial lung diseases Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008
Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006